Anesthetic effect

The term "Anesthetic effect" refers to a drug-induced, reversible physiological state characterized by a loss of sensation, consciousness, and memory, rather than a specific molecular target like a receptor or enzyme [2, 7]. This pharmacological state is produced by the interaction of anesthetic agents with a diverse array of proteins in the central and peripheral nervous systems, primarily ligand-gated and voltage-gated ion channels [3, 6, 9]. Local anesthetics achieve their effect by blocking voltage-gated sodium channels to stop nerve impulse conduction, while general anesthetics modulate targets such as Gamma-aminobutyric acid type A (GABA-A) receptors, N-methyl-D-aspartate (NMDA) receptors, and two-pore-domain potassium channels [5, 9, 11]. Because it describes a clinical endpoint or physiological outcome rather than a discrete biological entity, "Anesthetic effect" is not considered a valid therapeutic target in the context of molecular pharmacology [2, 7].

Other names

AnesthesiaGeneral anesthesiaLocal anesthesiaLoss of sensationPharmacological sedationNarcosis

The anesthetic effect is a multi-target phenomenon. Local anesthetics primarily bind to and inhibit voltage-gated sodium channels (Nav), preventing the depolarization of nerve membranes and the propagation of pain signals [1, 9, 12]. General anesthetics act through various mechanisms, including the enhancement of inhibitory neurotransmission at GABA-A and glycine receptors, the inhibition of excitatory neurotransmission at NMDA and nicotinic acetylcholine receptors, and the activation of two-pore-domain potassium channels (K2P) to reduce neuronal excitability [3, 4, 5, 9].